首页> 美国卫生研究院文献>International Journal of Clinical and Experimental Pathology >Bladder papillary urothelial neoplasm of low malignant potential in Chinese: a clinical and pathological analysis
【2h】

Bladder papillary urothelial neoplasm of low malignant potential in Chinese: a clinical and pathological analysis

机译:中国人恶性潜能低的膀胱乳头尿路上皮肿瘤的临床和病理分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Papillary urothelial neoplasm of low malignant potential (PUNLMP) had the incidence of low and definitive recurrence. Therefore, few studies showed that the relationship between pathological factors and the prognosis of patients with PUNLMP. The aim of this study assessed the linkage of pathological factors and prognosis of patients with PUNLMP including the presence or absence of mitoses and the thickness of urothelium. A retrospective analysis of 71 patients with PUNLMP was enrolled between January 2007 and June 2013. The clinicopathological factors consisting of tumor diameter, multifocality, the presence or absence of mitoses and cell thickness of urothelium were retrieved, Log-rank test and Cox proportional hazards regression models were used for univariate and multivariate analyses to evaluate the associations of these factors with recurrence-free survival (RFS) and progression-free survival (PFS).The incidence of recurrence and progression for PUNLMP was 19.7% and 16.9%, respectively. Patients with grade progression represented 85.7% in the recurrent patients. No patients had stage progression and no cases died from invasive urothelial carcinoma. Univariate analysis showed that the presence of mitoses, tumor diameter greater than or equal to 0.8 cm, multifocality were significantly correlated with worse RFS (P < 0.05) and PFS (P < 0.05). Multivariate analysis demonstrated that the presence of mitoses, tumor multifocality were significantly independent biomarkers for worse RFS (P < 0.05) and PFS (P < 0.05). Although the rare and infrequent mitoses were found for PUNLMP, the presence of mitoses and tumor multifocality were still the independent and poor predictors for the prognosis of PUNLMP. In addition, once the PUNLMP appeared to the recurrence, the inevitable grade progression could be determined, herein, long-term follow-up was necessary to be warranted, especially for patients with multiple lesions and the presence of mitoses.
机译:低恶性乳头状尿路上皮肿瘤(PUNLMP)的发生率低且确定性复发。因此,很少有研究表明病理因素与PUNLMP患者的预后有关。这项研究的目的是评估病理因素与PUNLMP患者预后的联系,包括是否存在有丝分裂和尿路上皮厚度。回顾性分析2007年1月至2013年6月的71例PUNLMP患者。检索了包括肿瘤直径,多灶性,有丝分裂是否存在以及尿路上皮细胞厚度在内的临床病理因素,对数秩检验和Cox比例风险回归使用模型进行单变量和多变量分析,以评估这些因素与无复发生存期(RFS)和无进展生存期(PFS)的关联.PUNLMP的复发和进展发生率分别为19.7%和16.9%。有复发进展的患者占复发患者的85.7%。没有患者有阶段进展,没有病例死于浸润性尿路上皮癌。单因素分析表明,存在有丝分裂,肿瘤直径大于或等于0.8 cm,多灶性与较差的RFS(P <0.05)和PFS(P <0.05)显着相关。多变量分析表明,有丝分裂,肿瘤多灶性是RFS(P <0.05)和PFS(P <0.05)恶化的显着独立生物标志。尽管发现PUNLMP的罕见和罕见的有丝分裂,但有丝分裂和肿瘤多灶性仍然是PUNLMP预后的独立且较差的预测因素。此外,一旦PUNLMP出现复发,就可以确定不可避免的分级进展,因此,有必要进行长期随访,特别是对于有多个病变和有丝分裂的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号